Invenomic Capital Management LP Fonar Corp Transaction History

Invenomic Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$15.4 - $17.47 $79,233 - $89,883	5,145 Added 4.42%	121,547 $1.87 Million
Q2 2023 Aug 14, 2023	SELL	$15.27 - $17.94 $231,004 - $271,396	-15,128 Reduced 11.5%	116,402 $1.99 Million
Q1 2023 May 15, 2023	BUY	$15.4 - $18.75 $49,926 - $60,787	3,242 Added 2.53%	131,530 $2.13 Million
Q4 2022 Feb 14, 2023	SELL	$14.95 - $18.82 $102,437 - $128,954	-6,852 Reduced 5.07%	128,288 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$13.31 - $15.36 $917,724 - $1.06 Million	68,950 Added 104.17%	135,140 $1.91 Million
Q2 2022 Aug 15, 2022	SELL	$15.19 - $19.05 $180,442 - $226,294	-11,879 Reduced 15.22%	66,190 $1.01 Million
Q1 2022 May 16, 2022	BUY	$14.53 - $19.1 $17,232 - $22,652	1,186 Added 1.54%	78,069 $1.15 Million
Q4 2021 Feb 11, 2022	BUY	$14.55 - $18.6 $325,105 - $415,598	22,344 Added 40.97%	76,883 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$15.44 - $17.77 $599,303 - $689,742	38,815 Added 246.85%	54,539 $843,000
Q2 2021 Aug 16, 2021	BUY	$16.58 - $19.0 $260,703 - $298,756	15,724 New	15,724 $278,000

3.09M

Ticker FONR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,554,210
Market Cap $100M
Description
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic servi...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.